Nuvo Pharmaceuticals Inc. buy tbackenh
Start price
15.09.21
/
60%
€0.94
Target price
15.09.22
€1.20
Performance (%)
11.23%
End price
05.12.21
€1.04
Summary
This prediction ended on 05.12.21 with a price of €1.04. The BUY prediction by tbackenh finished with a performance of 11.23%. tbackenh has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nuvo Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% |
According to tbackenh what are the pros and cons of Nuvo Pharmaceuticals Inc. for the foreseeable future?
Pros
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Cons
Higher risks for its business
Below average Marketposition
Comments by tbackenh for this prediction
In the thread Nuvo Pharmaceuticals Inc. diskutieren
Buy Nuvo Pharmaceuticals Inc.
Kursziel geändert auf 1,2